Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04594928
What this trial is testing

A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Lakefront Biotherapeutics NV 30
Testing effectiveness (Phase 2)Study completedNCT02618616
What this trial is testing

Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis
Ziarco Pharma Ltd 129
Large-scale testing (Phase 3)Study completedNCT04102007
What this trial is testing

The Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab

Who this might be right for
Plaque Psoriasis
AbbVie 244
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Early research (Phase 1)Study completedNCT03724292
What this trial is testing

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Who this might be right for
Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate 40
Early research (Phase 1)Study completedNCT05442788
What this trial is testing

HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Huabo Biopharm Co., Ltd. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05565560
What this trial is testing

Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 17
Testing effectiveness (Phase 2)Ended earlyNCT03358290
What this trial is testing

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisSkin Diseases
Akros Pharma Inc. 13
Not applicableLooking for participantsNCT07582783
What this trial is testing

Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 200
Testing effectiveness (Phase 2)Study completedNCT02209753
What this trial is testing

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 182
Large-scale testing (Phase 3)Study completedNCT01722331
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 772
Post-approval studies (Phase 4)Study completedNCT01059773
What this trial is testing

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

Who this might be right for
Psoriasis
Janssen-Cilag International NV 490
Large-scale testing (Phase 3)Study completedNCT05335356
What this trial is testing

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 384
Testing effectiveness (Phase 2)Study completedNCT02407041
What this trial is testing

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

Who this might be right for
Psoriasis
Galectin Therapeutics Inc. 5
Post-approval studies (Phase 4)Study completedNCT05855967
What this trial is testing

Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Eli Lilly and Company 250
Large-scale testing (Phase 3)Study completedNCT01474512
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 1,296
Large-scale testing (Phase 3)Study completedNCT02203032
What this trial is testing

Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 872
Large-scale testing (Phase 3)Study completedNCT05377944
What this trial is testing

Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 502
Large-scale testing (Phase 3)Study completedNCT03777436
What this trial is testing

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

Who this might be right for
Psoriasis
Amgen 289
Large-scale testing (Phase 3)Study completedNCT03482011
What this trial is testing

Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 530
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation